Surgical procedures could become faster, gentler, and safer in the future. Researchers at the Massachusetts Institute of Technology (MIT) in the United States have developed a special biological adhesive that can bond human tissues without traditional stitching. This nature-inspired technology has already received initial regulatory approvals and is expected to enter further clinical trials in 2027.
Heart surgeries, Cesarean sections, or procedures for tendon injuries all have one thing in common: surgeons often have to precisely join individual tissues. Traditionally, they use surgical sutures or clips. However, this process can be time-consuming and carries the risk of damaging surrounding tissues in complex procedures.
The American company SanaHeal, which was founded based on MIT research, is now offering an alternative. They have developed a special biocompatible adhesive that can quickly and firmly adhere to both wet and uneven surfaces of the human body.
The material creates a tight seal that prevents the penetration of air and bodily fluids. In the future, it could potentially replace surgical sutures in some cases and significantly simplify complex operations.
Scientists found inspiration in nature
The developers were inspired by organisms that can adhere extremely strongly to various surfaces. These include, for example, marine snails, which cling to rocks or ship hulls, and spiders that create adhesive fibers.
The ability to adhere to a wet surface was one of the biggest technical challenges. Human tissues are naturally moist and come into contact with blood and other bodily fluids during surgical procedures.
Researchers therefore used hydrogels, which are soft materials made of polymers and water. Their properties allow for the creation of strong bonds while also minimizing unwanted reactions in the body.
“Our solution is more like a Post-it note,” explained Hyunwoo Yuk, founder of SanaHeal and its chief technology officer. According to him, the technology is less invasive and easier to use, even in robot-assisted surgeries.
It has already received approval, and further testing will begin next year
According to MIT, the technology has already received regulatory approval for use in stopping bleeding caused by injuries. This is a significant step on the path from laboratory research to actual use in medicine.
Further clinical trials on humans are planned for 2027. These will focus primarily on stopping bleeding during surgeries and repairing damaged tissues.
The developers are also collaborating with larger medical device manufacturers. They are exploring the possibilities of using the material in open surgeries, laparoscopic and endoscopic procedures, or in hernia and nerve repairs.
If the safety and effectiveness of the technology are also confirmed in clinical studies, it could gradually reduce the need for some surgical sutures, shorten the duration of operations, and reduce their costs.
Traditional stitching will of course not disappear from medicine in the foreseeable future. However, the new material shows that even procedures used for centuries can take on a completely new form thanks to modern research.
Jaroslav Holý
